The Science of Influence: Using Behavioral Economics to Improve Pharma Marketing
Prescribing decisions rarely happen in a purely rational way. Even though clinical evidence plays a central role, physicians often rely on mental shortcuts, experience,...
Owning the Disease Conversation: The New Playbook for Therapeutic Area Leadership
Pharmaceutical brands no longer compete only on product performance. Instead, many now compete to shape the broader conversation around disease understanding and patient education....
Real-World Evidence Marketing: Turning Clinical Data Into Commercial Influence
Real-world data is everywhere in healthcare today. Hospitals collect outcomes data, patient registries track long-term treatment results, and insurers analyze therapy effectiveness at scale....
The Public Health Pivot: How Pharma Brands Are Partnering with Governments to Drive Impact
Pharmaceutical companies have traditionally focused on developing and marketing therapies. However, healthcare systems now face challenges that demand broader collaboration. Governments, public health agencies,...
From Support to Strategy: How Patient Support Programs Are Reshaping Pharma Marketing
Patient support programs were once viewed as helpful services that assist patients after a prescription is written. However, the healthcare landscape has changed dramatically....
The Medical Affairs Revolution: Why Scientific Engagement Is Becoming Pharma Marketing’s Strategic Core
For decades, pharmaceutical marketing teams controlled the narrative around clinical evidence, product positioning, and brand messaging. Today, however, that dynamic is shifting.
A new pharma...
The Talent Equation: Where Pharma Marketing Capabilities Should Live in the AI Era
Artificial intelligence is changing the pace of pharmaceutical marketing. Campaigns that once required weeks of production can now move from concept to launch in...
One Story, Two Audiences: Aligning Wall Street Expectations with Brand Messaging
Investor expectations now shape how pharmaceutical companies communicate about pipelines, pricing, and long-term growth. Because of this shift, alignment between pharma investor relations and...
Data Is Leverage: Power, Platforms, and Pharma’s Fight for Control
Healthcare data now drives nearly every modern marketing decision in the pharmaceutical industry. However, as pharmaceutical companies collaborate with EHR vendors, retail platforms, analytics...
26th DTC National Conference
The 26th Annual DTC National Conference will take place April 21–23, 2026, bringing together leaders, innovators, and decision-makers to explore the evolving...
